BioSpace News Archive

Taysha Gene Therapies, a patient-centric gene therapy company with a mission to eradicate monogenic CNS diseases, announced that it has received Orphan Drug Designation and Rare Pediatric Disease Designation from the U.S. Food and Drug Administration for TSHA-101, an AAV9-based gene therapy in development for GM2 Gangliosidosis.

Bayer and Northpond Ventures Lead USD $55 Million Series A Financing Round for Triumvira Immunologics Leaps by Bayer and Northpond Ventures co-lead the investment to support development of next-generation immuno oncology treatments Triumvira’s T-cell therapies have transformative potential as a new type of cancer treatment that uses the immune system to fight cancer Pipeline includes four therapeutics candidates for both autologous and allogen

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and inflammatory diseases, announced financial results for the six months ended June 30, 2020.

Hepion Pharmaceuticals, Inc. today announced that it will present a poster on CRV431’s antifibrotic activity at the Digital International Liver Congress™ 2020 (EASL), taking place from August 27-29, 2020.

Sutures, generally called stitches, are sterilized, surgical threads that are used for wound closure. They are primarily used to close incisions resulting due to a surgery.

The heightening awareness among the global populace for maintaining hygiene may serve as an efficient growth factor for the antiseptic and disinfectant market.

Incontinence refers to the lack of voluntary control over one’s bodily functions of defecation or urination.

Medical waste incinerator is mainly used for burning wastes produced by medical research facilities, veterinary facilities and hospitals.

Oral care domain includes a wide range of treatment and products that are designed to enhance oral hygiene and deliver dental care.

Increased prevalence of various degenerative bone disease, such as rheumatoid arthritis, curvature of the spine, bone cancer, and cervical spondylitis is estimated to accelerate the growth of the global orthopedic devices market in the forthcoming years.